Figure 8
From: Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage
Squalestatin reduces PAF-induced prostaglandin E2production. The amounts of prostaglandin E2 (pg/ml) produced by untreated neurons incubated with different concentrations of PAF (●) or lyso-PAF (▲) or neurons pre-treated with 100 nM squalestatin and incubated with varying concentrations of PAF (○). Values shown are the mean prostaglandin E2 ± SD from 9 observations.